Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.
about
Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosisTargeting the overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in esophageal cancer cellsChloroquine alleviates etoposide-induced centrosome amplification by inhibiting CDK2 in adrenocortical tumor cells.Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo.Induction of autophagy promotes the growth of early preneoplastic rat liver nodules.Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells.Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.MLN4924 therapy as a novel approach in cancer treatment modalities.Therapeutic potentials of short interfering RNAs.Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor.Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase.HIF-1α Inhibition Sensitized Pituitary Adenoma Cells to Temozolomide by Regulating Presenilin 1 Expression and Autophagy.MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcomaSystemic inhibition of neddylation by 3-day MLN4924 treatment regime does not impair autophagic flux in mouse hearts and brains.Protein neddylation and its alterations in human cancers for targeted therapy.Chloroquine exerts antitumor effects on NB4 acute promyelocytic leukemia cells and functions synergistically with arsenic trioxide.
P2860
Q28829690-B83CEAA2-AF0B-4898-815E-5F8EDA5C3056Q33710037-A32C4BE3-0FD5-4481-BDBC-E3497DA44E07Q36396549-2A3B7305-0FCF-44BB-8CF1-8A9F48BCA85CQ36425775-BE0B5F8E-93D7-420F-9F4D-A45B7D88523AQ36905775-C883B0CB-2069-4363-A386-3786B50EF2C6Q37164378-528295BA-8F51-4DC7-B14D-519D0EFF7A0BQ37662370-83797A81-214C-447E-87E2-BFA18AFFAFE4Q38570362-6722A55D-12C7-4DB3-BB8D-514FE484E47DQ38645080-4039503B-9E39-44FF-A415-397A7D91483FQ38712272-7E504167-DB16-44D2-9F5D-232351552D73Q38813861-53263FA6-5607-4C63-9E51-E490EC4F9B77Q40231870-B47D70E1-8C8C-49B9-B39B-B577DD0632D9Q40851893-3DF466FF-FFC5-488F-91B0-FFFC022B9473Q47852778-17698929-EEAB-4DC2-A1B1-34C192FA82E3Q48538797-5318D57F-A357-4917-BD74-1089A8BA6C2EQ50053658-8B4AC99A-EB8A-4B03-A5B7-86613BA7D968
P2860
Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Synergistic inhibition of auto ...... ch for targeting liver cancer.
@ast
Synergistic inhibition of auto ...... ch for targeting liver cancer.
@en
type
label
Synergistic inhibition of auto ...... ch for targeting liver cancer.
@ast
Synergistic inhibition of auto ...... ch for targeting liver cancer.
@en
prefLabel
Synergistic inhibition of auto ...... ch for targeting liver cancer.
@ast
Synergistic inhibition of auto ...... ch for targeting liver cancer.
@en
P2093
P2860
P356
P1433
P1476
Synergistic inhibition of auto ...... ch for targeting liver cancer.
@en
P2093
Chunjie Li
Dongping Wei
Lak Shin Jeong
Ping Zhang
Robert M Hoffman
P2860
P304
P356
10.18632/ONCOTARGET.3282
P407
P577
2015-04-01T00:00:00Z